Briefing
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Recruiting phase 2 trial of adaptive de-intensified radiotherapy guided by circulating tumor DNA in HPV-associated oropharyngeal cancer (planned n=45).
- Design: Phase 2 · Recruiting